Generic name:haemophilus b and meningococcal conjugate vaccine [ hem-OFF-il-us-B-and-me-NIN-je-KOK-al-KON-je-gate-vax-EEN ]
Drug class:Bacterial vaccines
Medically reviewed by Drugs.com. Last updated on Nov 29, 2021.
What is MenHibrix?
MenHibrix vaccine is used to help prevent haemophilus B and meningococcal disease in children.
Haemophilus influenzae type B (Hib) is a bacteria that can cause serious illness, including breathing problems or meningitis. Hib infection usually affects children and can be fatal.
Meningococcal disease is a serious infection caused by a bacteria. Meningococcal bacteria can infect the blood, spinal cord, and brain, and can cause meningitis. These conditions can be fatal.
Haemophilus B and meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle, or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.
MenHibrix works by exposing your child to a small dose of bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. MenHibrix will not treat an active infection that has already developed in the body.
MenHibrix is for use in children between the ages of 6 weeks and 18 months old.
Like any vaccine, MenHibrix may not provide protection from disease in every person.
Warnings
Your child should not receive MenHibrix if he or she has ever had a life threatening allergic reaction to any meningococcal, haemophilus B, or tetanus vaccine.
Before your child receives MenHibrix, tell your doctor if the child has a weak immune system, if the child was born prematurely, or if the child has ever had Guillain-Barré syndrome within 6 weeks after receiving a vaccine t...
